Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

Explore this paper's citation graph

Summary

Long-term survival rates from patients treated at 77 institutions demonstrate that ulceration and tumor thickness are dominant predictive factors that should be used in the staging of stages I and II melanomas, and confer a survival advantage for these subgroups of prospectively defined melanoma patients.

Type
article
Published
2000-03-01
Cited by
426
References
46

Keywords

Medicine, Melanoma, Randomized controlled trial, Surgical oncology, Surgery

References

Cited by

Related papers